Publication | Closed Access
Combination of TAS-102 and bevacizumab as third-line treatment for metastatic colorectal cancer: TAS-CC3 study
42
Citations
19
References
2020
Year
Gastrointestinal OncologyMedicinePathologyColorectal CancerMetastatic Colorectal CancerCancer TreatmentThird-line TreatmentOncologyRadiation OncologyMolecular Oncology
| Year | Citations | |
|---|---|---|
Page 1
Page 1